Unprovoked venous thromboembolism: short term or indefinite anticoagulation? Balancing long-term risk and benefit
Whether to continue oral anticoagulant therapy indefinitely after completing 3 to 6months of
oral anticoagulant therapy for “unprovoked” venous thromboembolism (VTE), is one of the …
oral anticoagulant therapy for “unprovoked” venous thromboembolism (VTE), is one of the …
[HTML][HTML] Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous …
Background The long‐term risk for recurrent venous thromboembolism (VTE) during
extended anticoagulation for a first unprovoked VTE is uncertain. Objectives To determine …
extended anticoagulation for a first unprovoked VTE is uncertain. Objectives To determine …
[HTML][HTML] Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta …
Background The optimal duration of anticoagulation after a first unprovoked venous
thromboembolism (VTE) remains controversial. Deciding to stop or continue anticoagulant …
thromboembolism (VTE) remains controversial. Deciding to stop or continue anticoagulant …
Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and meta-analysis
Background: The long-term risk for major bleeding in patients receiving extended (beyond
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event …
Objectives To determine the rate of a first recurrent venous thromboembolism (VTE) event
after discontinuation of anticoagulant treatment in patients with a first episode of unprovoked …
after discontinuation of anticoagulant treatment in patients with a first episode of unprovoked …
Duration of anticoagulation following venous thromboembolism: a meta-analysis
D Ost, J Tepper, H Mihara, O Lander, R Heinzer, A Fein - Jama, 2005 - jamanetwork.com
ContextPatients with venous thromboembolism (VTE) are susceptible to recurrent events,
but whether prolonging anticoagulation is warranted in patients with VTE remains …
but whether prolonging anticoagulation is warranted in patients with VTE remains …
Indefinite anticoagulant therapy for first unprovoked venous thromboembolism: a cost-effectiveness study
Background: Clinical practice guidelines recommend indefinite anticoagulation for a first
unprovoked venous thromboembolism (VTE). Objective: To estimate the benefit–harm …
unprovoked venous thromboembolism (VTE). Objective: To estimate the benefit–harm …
[HTML][HTML] Anticoagulation for patients with venous thromboembolism: when is extended treatment required?
JI Weitz, P Prandoni, P Verhamme - TH Open, 2020 - thieme-connect.com
The need for extended venous thromboembolism (VTE) treatment beyond 3 to 6 months is
usually determined by balancing the risk of recurrence if treatment is stopped against the …
usually determined by balancing the risk of recurrence if treatment is stopped against the …
Long-Term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis
Background The long-term risk of major bleeding after discontinuing anticoagulant therapy
for a first unprovoked venous thromboembolism (VTE) is uncertain. Objectives To determine …
for a first unprovoked venous thromboembolism (VTE) is uncertain. Objectives To determine …
[HTML][HTML] Short-term versus extended anticoagulant treatment for unprovoked venous thromboembolism: A survey on guideline adherence and physicians' …
MA de Winter, GCP Remme, KHAH Kaasjager… - Thrombosis …, 2019 - Elsevier
Background In patients with unprovoked venous thromboembolism (VTE), anticoagulant
treatment duration should be decided by weighing bleeding risk versus risk of recurrent VTE …
treatment duration should be decided by weighing bleeding risk versus risk of recurrent VTE …